Goserelin clinical trials: 100 trials
Page 2 of 2
- A Study of Lerociclib in Participants With Advanced Breast Cancer
NCT05085002 · Phase 2 · Terminated
Posted results
- Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal Women
NCT00322348 · Phase 2 · Completed
Posted results
- The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer
NCT01790126 · Phase 2 · Completed
Posted results
- PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
NCT01723774 · Phase 2 · Active, not recruiting
Posted results
- Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
NCT00081159 · Phase 2 · Completed
Posted results
- A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer
NCT02059213 · Phase 2 · Completed
Posted results
- LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer
NCT02058706 · Phase 2 · Completed
Posted results
- Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer
NCT01088529 · Phase 2 · Completed
Posted results
- Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer
NCT02168062 · Phase 2 · Terminated
Posted results
- Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer
NCT03007979 · Phase 2 · Completed
Posted results
- A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer
NCT00108732 · Phase 2 · Completed
Posted results
- Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors
NCT04126070 · Phase 2 · Active, not recruiting
Posted results
- Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer
NCT00658697 · Phase 2 · Completed
Posted results
- S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
NCT00028769 · Phase 2 · Completed
Posted results
- Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer
NCT01076335 · Phase 2 · Completed
Posted results
- Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer
NCT02430480 · Phase 2 · Completed
Posted results
- Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer
NCT00500110 · Phase 2 · Completed
Posted results
- Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer
NCT00454571 · Phase 2 · Completed
Posted results
- Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle
NCT00586898 · Phase 2 · Completed
Posted results
- Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women
NCT00186121 · Phase 2 · Completed
Posted results
- Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer
NCT00298155 · Phase 2 · Completed
Posted results
- Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
NCT00016913 · Phase 2 · Completed
Posted results
- Bipolar Androgen-based Therapy for Prostate Cancer (BAT)
NCT01750398 · Phase 2 · Completed
Posted results
- Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer
NCT00283803 · Phase 2 · Completed
Posted results
- Ipilimumab + Androgen Depravation Therapy in Prostate Cancer
NCT01377389 · Phase 2 · Terminated
Posted results
- Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
NCT00544830 · Phase 2 · Active, not recruiting
Posted results
- Tecemotide (L-BLP25) in Prostate Cancer
NCT01496131 · Phase 2 · Completed
Posted results
- Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer
NCT01250717 · Phase 2 · Completed
Posted results
- Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer
NCT00669162 · Phase 1/2 · Completed
Posted results
- Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer
NCT02907918 · Phase 2 · Terminated
Posted results
- Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
NCT03361735 · Phase 2 · Active, not recruiting
Posted results
- Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer
NCT01023061 · Phase 2 · Completed
Posted results
- Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer
NCT00225420 · Phase 1/2 · Completed
Posted results
- Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer
NCT02278185 · Phase 2 · Completed
Posted results
- Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
NCT00589472 · Phase 2 · Completed
Posted results
- Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
NCT00937768 · Phase 2 · Terminated
Posted results
- Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer
NCT01776008 · Phase 2 · Terminated
Posted results
- Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast Cancer
NCT01205685 · Phase 2 · Terminated
Posted results
- Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer
NCT01163084 · Phase 1/2 · Terminated
Posted results
- Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer
NCT01368263 · Phase 2 · Terminated
Posted results
- Pilot Decentralized Clinical Trial in Men and Pre and Post-menopausal Women With Breast Cancer and a Specific Mutation (PIK3CA) Treated With Alpelisib in Combination With Fulvestrant
NCT04862143 · Phase 2 · Terminated
Posted results
- Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA
NCT01531205 · Phase 2 · Terminated
Posted results
- Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients
NCT06225284 · Phase 2 · Recruiting
Linked paper with results
- Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer
NCT00328614 · Phase 1 · Completed
Posted results
- Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer
NCT05617885 · Phase 1 · Terminated
Posted results
- TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer
NCT02586675 · Phase 1 · Completed
Posted results
- Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
NCT05701007 · Phase not stated · Completed
Posted results
- Dose-Response of Gonadal Steroids and Bone Turnover in Older Men
NCT00114114 · Not applicable · Completed
Posted results
- Neuropsychobiological Correlates of Sex-steroid Hormone Manipulation in Healthy Women: a Risk Model for Depression
NCT02661789 · Not applicable · Completed
Linked paper with results
- BMD Alterations and Bone and Muscle Parameters During Menstrual Cessation With GnRH
NCT04203212 · Phase not stated · Completed
Linked paper with results